Analyst Ranking
Top 7%
#324 out of 5020 analysts
Average Return
+14.27%
Win Rate
45%81 out of 179
Risk vs Reward
Poor
Good

Laura Chico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Longboard Pharmaceuticals IncLBPH
+658.28%$5.13$38.90
2023-10-11 -
2024-10-11
Buy
Edgewise Therapeutics IncEWTX
+560.25%$5.51$36.38
2023-11-09 -
2024-11-08
Buy
Vigil Neuroscience IncVIGL
+290.10%$2.02$7.88
2025-03-13 -
2025-05-22
Buy
Tourmaline Bio IncTRML
+232.45%$14.33$47.64
2025-03-05 -
2025-09-09
Buy
Longboard Pharmaceuticals IncLBPH
+200.50%$19.96$59.98
2024-03-12 -
2024-11-29
Buy

Laura Chico Analyst Color

Get additional color on Laura Chico's coverage of popular stocks

Laura Chico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dianthus Therapeutics IncDNTH
9Buy$44.00+13.17%Maintains
6 days ago
Tourmaline Bio IncTRML
3Hold$48.00+0.63%Downgrades
9 days ago
Jade Biosciences IncJBIO
6Buy$18.00+158.99%Maintains
a month ago
Solid Biosciences IncSLDB
3Buy$14.00+155.94%Maintains
a month ago
Stoke Therapeutics IncSTOK
7Buy$22.00-3.25%Maintains
a month ago
Xenon Pharmaceuticals IncXENE
9Buy$43.00+17.17%Maintains
a month ago
Travere Therapeutics IncTVTX
12Buy$32.00+35.31%Maintains
a month ago
Gossamer Bio IncGOSS
6Buy$5.00+67.22%Maintains
a month ago
Ardelyx IncARDX
14Buy$14.00+126.17%Maintains
a month ago
Neurocrine Biosciences IncNBIX
10Buy$141.00-1.21%Maintains
2 months ago
Ultragenyx Pharmaceutical IncRARE
12Hold$34.00+18.43%Maintains
2 months ago
Maze Therapeutics IncMAZE
1Buy$17.00-27.66%Initiates Coverage On
2 months ago
Biocryst Pharmaceuticals IncBCRX
1Buy$18.00+133.77%Maintains
3 months ago
Larimar Therapeutics IncLRMR
2Buy$15.00+267.65%Maintains
3 months ago
Lennar CorpLEN
1Hold$130.00-2.23%Reiterates
3 months ago
Biogen IncBIIB
15Hold$121.00-16.48%Reiterates
3 months ago
Pharvaris NvPHVS
7Buy$27.00+12.13%Reiterates
3 months ago
Vigil Neuroscience IncVIGL
11Hold$8.00-0.62%Downgrades
4 months ago
Alto Neuroscience IncANRO
4Hold$4.00+4.71%Reiterates
4 months ago
Vera Therapeutics IncVERA
8Hold$26.00+5.95%Maintains
4 months ago
Denali Therapeutics IncDNLI
8Buy$30.00+129.71%Maintains
4 months ago
Praxis Precision Medicines IncPRAX
7Sell$28.00-36.41%Maintains
4 months ago
Edgewise Therapeutics IncEWTX
10Buy$43.00+209.58%Maintains
5 months ago
Ovid Therapeutics IncOVID
2Buy$3.00+158.62%Maintains
6 months ago
Astria Therapeutics IncATXS
9Buy$28.00+278.89%Maintains
6 months ago
Apellis Pharmaceuticals IncAPLS
13Hold$29.00+25.38%Maintains
7 months ago
Sage Therapeutics IncSAGE
7Hold$6.00-30.88%Reiterates
7 months ago
Pepgen IncPEPG
10Buy$12.00+541.71%Maintains
10 months ago
Longboard Pharmaceuticals IncLBPH
7Buy$44.00N/AMaintains
a year ago
Voyager Therapeutics IncVYGR
3Hold$7.00N/AMaintains
a year ago
Viridian Therapeutics IncVRDN
7Buy$42.00N/AReiterates
a year ago
Rallybio CorpRLYB
4Buy$11.00N/AMaintains
a year ago
Design Therapeutics IncDSGN
5Hold$5.00N/AReiterates
a year ago
Karuna Therapeutics IncKRTX
4Hold$330.00N/ADowngrades
2 years ago
Chinook Therapeutics IncKDNY
3Hold$42.00N/ADowngrades
2 years ago
Impel Pharmaceuticals IncIMPLQ
2Hold$5.00N/ADowngrades
3 years ago
Taysha Gene Therapies IncTSHA
2Buy$5.00N/AMaintains
3 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Hold$148.50N/ADowngrades
3 years ago
Viela Bio IncVIE
2HoldN/AN/ADowngrades
5 years ago
Biomarin Pharmaceutical IncBMRN
3Buy$110.00N/AReinstates
6 years ago
Acer Therapeutics IncACER
2Buy$40.00N/AReinstates
7 years ago
Paratek Pharmaceuticals IncPRTK
2BuyN/AN/ADowngrades
8 years ago
Bioverativ IncBIVV
1HoldN/AN/ADowngrades
8 years ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$720.00N/AInitiates Coverage On
8 years ago
Cidara Therapeutics IncCDTX
1Strong Buy$280.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.